Skip to content

Drybench Patent.

Patent and exclusivity dates from July to December 2036 for NDAs, as FDA's Orange Book lists them

Each patent and exclusivity date from July to December 2036 that FDA's Orange Book lists for an NDA, as captured on 14 October 2026. That capture lists a patent or exclusivity for 1,411 NDAs. Each entry is named by its rule and linked to its NDA page. A date here belongs to one patent or one exclusivity on the products named; the same NDA may have other listed dates, earlier or later, so no date here stands for a product.

FDA capture · review pending. Each date is shown as captured from FDA's Orange Book files. Dates are as FDA lists them, and Drybench computes none; patent dates are submitted by the applicant, and FDA does not verify them. Spreadsheet day numbers are shown as dates; a cell that cannot be read as one date is left off this page and shown as written on its NDA page. Where FDA lists a *PED row without flags, its flags are read from the base row and marked so. How this page reads FDA's files has not been independently reviewed by a regulatory-affairs reviewer.

Orange Book captured
14 October 2026

Listed protection is a range of the dates FDA lists, not a forecast of market entry, and not legal, regulatory or investment advice.

This page covers every NDA whose Orange Book capture lists a patent or exclusivity. It does not cover ANDAs or any BLA. NCE exclusivity dates are here as FDA lists them; NCE-1 dates, computed from them, are on the NCE-1 calendar.

Dates as listed in FDA's Orange Book capture of 14 October 2026. This page does not say whether a date has passed; compare it with today's date and FDA's current Orange Book. This page shows only what the capture of 14 October 2026 lists. It does not show patents or exclusivities listed before and since removed.

NCE-1, one year before a listed NCE exclusivity date and the one date Drybench computes, is on its own page: NCE-1 dates from the Orange Book

Listed dates, 2036January to June 2036

Listed patent expiry (278)

  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 10,167,291, product and use patent

    patent.txt line 11,231
    Flags
    product use code U-2145
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 10,167,291, product and use patent

    patent.txt line 11,232
    Flags
    product use code U-2519
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 10,167,291, product and use patent

    patent.txt line 11,233
    Flags
    product use code U-2666
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 10,167,291, product and use patent

    patent.txt line 11,234
    Flags
    product use code U-2667
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 10,167,291, product and use patent

    patent.txt line 11,235
    Flags
    product use code U-2668
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 10,167,291, product and use patent

    patent.txt line 11,236
    Flags
    product use code U-2669
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 10,167,291, product and use patent

    patent.txt line 11,237
    Flags
    product use code U-2670
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 10,167,291, product and use patent

    patent.txt line 11,238
    Flags
    product use code U-2671
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 10,167,291, product and use patent

    patent.txt line 11,239
    Flags
    product use code U-2682
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 10,167,291, product and use patent

    patent.txt line 11,240
    Flags
    product use code U-2683
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 10,167,291, product and use patent

    patent.txt line 11,241
    Flags
    product use code U-2684
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 10,167,291, product and use patent

    patent.txt line 11,242
    Flags
    product use code U-2685
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 10,167,291, product and use patent

    patent.txt line 11,243
    Flags
    product use code U-2686
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 10,167,291, product and use patent

    patent.txt line 11,244
    Flags
    product use code U-2687
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 10,167,291, product and use patent

    patent.txt line 11,245
    Flags
    product use code U-4109
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 9,796,721, substance and product and use patent

    patent.txt line 11,267
    Flags
    substance product use code U-2145
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 9,796,721, substance and product and use patent

    patent.txt line 11,268
    Flags
    substance product use code U-2666
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 9,796,721, substance and product and use patent

    patent.txt line 11,269
    Flags
    substance product use code U-2667
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 9,796,721, substance and product and use patent

    patent.txt line 11,270
    Flags
    substance product use code U-2668
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 9,796,721, substance and product and use patent

    patent.txt line 11,271
    Flags
    substance product use code U-2669
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 9,796,721, substance and product and use patent

    patent.txt line 11,272
    Flags
    substance product use code U-2670
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 9,796,721, substance and product and use patent

    patent.txt line 11,273
    Flags
    substance product use code U-2671
    Product numbers
    001
  • 1 Jul 2036 · NDA 210259 · ACALABRUTINIB

    US 9,796,721, substance and product and use patent

    patent.txt line 11,274
    Flags
    substance product use code U-4108
    Product numbers
    001
  • 1 Jul 2036 · NDA 211349 · GILTERITINIB FUMARATE

    US 10,786,500, product patent

    patent.txt line 12,707
    Flags
    product
    Product numbers
    001
  • 1 Jul 2036 · NDA 211349 · GILTERITINIB FUMARATE

    US 11,938,130, product patent

    patent.txt line 12,708
    Flags
    product
    Product numbers
    001
  • 1 Jul 2036 · NDA 211349 · GILTERITINIB FUMARATE

    US 11,938,131, product patent

    patent.txt line 12,709
    Flags
    product
    Product numbers
    001
  • 1 Jul 2036 · NDA 211349 · GILTERITINIB FUMARATE

    US 11,938,132, product patent

    patent.txt line 12,710
    Flags
    product
    Product numbers
    001
  • 1 Jul 2036 · NDA 211349 · GILTERITINIB FUMARATE

    US 11,938,133, product patent

    patent.txt line 12,711
    Flags
    product
    Product numbers
    001
  • 1 Jul 2036 · NDA 211349 · GILTERITINIB FUMARATE

    US 11,944,620, product patent

    patent.txt line 12,712
    Flags
    product
    Product numbers
    001
  • 1 Jul 2036 · NDA 216387 · ACALABRUTINIB MALEATE

    US 11,059,829, substance and product and use patent

    patent.txt line 18,775
    Flags
    substance product use code U-2145
    Product numbers
    001
  • 1 Jul 2036 · NDA 216387 · ACALABRUTINIB MALEATE

    US 11,059,829, substance and product and use patent

    patent.txt line 18,776
    Flags
    substance product use code U-2666
    Product numbers
    001
  • 1 Jul 2036 · NDA 216387 · ACALABRUTINIB MALEATE

    US 11,059,829, substance and product and use patent

    patent.txt line 18,777
    Flags
    substance product use code U-2667
    Product numbers
    001
  • 1 Jul 2036 · NDA 216387 · ACALABRUTINIB MALEATE

    US 11,059,829, substance and product and use patent

    patent.txt line 18,778
    Flags
    substance product use code U-2668
    Product numbers
    001
  • 1 Jul 2036 · NDA 216387 · ACALABRUTINIB MALEATE

    US 11,059,829, substance and product and use patent

    patent.txt line 18,779
    Flags
    substance product use code U-2669
    Product numbers
    001
  • 1 Jul 2036 · NDA 216387 · ACALABRUTINIB MALEATE

    US 11,059,829, substance and product and use patent

    patent.txt line 18,780
    Flags
    substance product use code U-2670
    Product numbers
    001
  • 1 Jul 2036 · NDA 216387 · ACALABRUTINIB MALEATE

    US 11,059,829, substance and product and use patent

    patent.txt line 18,781
    Flags
    substance product use code U-2671
    Product numbers
    001
  • 1 Jul 2036 · NDA 216387 · ACALABRUTINIB MALEATE

    US 11,059,829, substance and product and use patent

    patent.txt line 18,782
    Flags
    substance product use code U-4108
    Product numbers
    001
  • 1 Jul 2036 · NDA 219249 · INAVOLISIB

    US 10,851,091, substance and product patent

    patent.txt lines 21,558, 21,565
    Flags
    substance product
    Product numbers
    001, 002
  • 1 Jul 2036 · NDA 219249 · INAVOLISIB

    US 11,760,753, use patent

    patent.txt lines 21,560, 21,567
    Flags
    use code U-4024
    Product numbers
    001, 002
  • 1 Jul 2036 · NDA 219249 · INAVOLISIB

    US 9,650,393, substance and product and use patent

    patent.txt lines 21,564, 21,571
    Flags
    substance product use code U-4024
    Product numbers
    001, 002
  • 5 Jul 2036 · NDA 218213 · REPOTRECTINIB

    US 10,294,242, substance patent

    patent.txt lines 20,906, 20,912
    Flags
    substance
    Product numbers
    001, 002
  • 5 Jul 2036 · NDA 218213 · REPOTRECTINIB

    US 12,187,739, product patent

    patent.txt lines 20,909, 20,915
    Flags
    product
    Product numbers
    001, 002
  • 19 Jul 2036 · NDA 208623 · MIGALASTAT HYDROCHLORIDE

    US 12,599,594, use patent

    patent.txt line 8,984
    Flags
    use code U-2371
    Product numbers
    001
  • 20 Jul 2036 · NDA 214253 · LEVOTHYROXINE SODIUM

    US 11,154,498, product patent

    patent.txt line 15,653
    Flags
    product
    Product numbers
    001
  • 20 Jul 2036 · NDA 218213 · REPOTRECTINIB

    US 12,310,968, use patent

    patent.txt lines 20,910, 20,916
    Flags
    use code U-3755
    Product numbers
    001, 002
  • 24 Jul 2036 · NDA 218213 · REPOTRECTINIB

    US 11,452,725, use patent

    patent.txt lines 20,907, 20,913
    Flags
    use code U-3755
    Product numbers
    001, 002
  • 24 Jul 2036 · NDA 218213 · REPOTRECTINIB

    US 11,452,725, use patent

    patent.txt lines 20,908, 20,914
    Flags
    use code U-3961
    Product numbers
    001, 002
  • 27 Jul 2036 · NDA 210868 · LORLATINIB

    US 10,420,749, substance and product and use patent

    patent.txt lines 12,259, 12,264
    Flags
    substance product use code U-2633
    Product numbers
    001, 002
  • 27 Jul 2036 · NDA 210868 · LORLATINIB

    US 10,420,749, substance and product and use patent

    patent.txt lines 12,260, 12,265
    Flags
    substance product use code U-3096
    Product numbers
    001, 002
  • 27 Jul 2036 · NDA 210868 · LORLATINIB

    US 11,020,376, product patent

    patent.txt lines 12,261, 12,266
    Flags
    product
    Product numbers
    001, 002
  • 28 Jul 2036 · NDA 215515 · VUTRISIRAN SODIUM

    US 10,208,307, substance and product and use patent

    patent.txt line 17,414
    Flags
    substance product use code U-3396
    Product numbers
    001
  • 28 Jul 2036 · NDA 215515 · VUTRISIRAN SODIUM

    US 10,683,501, substance and product and use patent

    patent.txt line 17,417
    Flags
    substance product use code U-3396
    Product numbers
    001
  • 28 Jul 2036 · NDA 215515 · VUTRISIRAN SODIUM

    US 11,286,486, substance and product and use patent

    patent.txt line 17,419
    Flags
    substance product use code U-3396
    Product numbers
    001
  • 28 Jul 2036 · NDA 215515 · VUTRISIRAN SODIUM

    US 12,049,628, substance and product and use patent

    patent.txt line 17,421
    Flags
    substance product use code U-3396
    Product numbers
    001
  • 1 Aug 2036 · NDA 214938 · VOSORITIDE

    US 10,646,550, product and use patent

    patent.txt lines 16,353, 16,361, 16,369
    Flags
    product use code U-3927
    Product numbers
    001, 002, 003
  • 1 Aug 2036 · NDA 214938 · VOSORITIDE

    US 11,590,204, product and use patent

    patent.txt lines 16,354, 16,362, 16,370
    Flags
    product use code U-3927
    Product numbers
    001, 002, 003
  • 1 Aug 2036 · NDA 214938 · VOSORITIDE

    US 11,911,446, use patent

    patent.txt lines 16,355, 16,363, 16,371
    Flags
    use code U-3927
    Product numbers
    001, 002, 003
  • 1 Aug 2036 · NDA 214938 · VOSORITIDE

    US 12,514,906, product and use patent

    patent.txt lines 16,357, 16,365, 16,373
    Flags
    product use code U-3927
    Product numbers
    001, 002, 003
  • 1 Aug 2036 · NDA 214938 · VOSORITIDE

    US 9,907,834, product patent

    patent.txt lines 16,359, 16,367, 16,375
    Flags
    product
    Product numbers
    001, 002, 003
  • 5 Aug 2036 · NDA 203826 · PHENYLEPHRINE HYDROCHLORIDE

    US 11,471,400, product patent

    patent.txt lines 4,161, 4,164
    Flags
    product
    Product numbers
    004, 005
  • 7 Aug 2036 · NDA 219792 · DOXECITINE; DOXRIBTIMINE

    US 10,471,087, use patent

    patent.txt line 22,008
    Flags
    use code U-4358
    Product numbers
    001
  • 9 Aug 2036 · NDA 220152 · TRADIPITANT

    US 12,318,375, use patent

    patent.txt line 22,111
    Flags
    use code U-4396
    Product numbers
    001
  • 12 Aug 2036 · NDA 202107 · MIFEPRISTONE

    US 10,006,924, use patent

    patent.txt line 2,756
    Flags
    use code U-1643
    Product numbers
    001
  • 12 Aug 2036 · NDA 202107 · MIFEPRISTONE

    US 10,495,650, use patent

    patent.txt line 2,763
    Flags
    use code U-1643
    Product numbers
    001
  • 13 Aug 2036 · NDA 212018 · ERDAFITINIB

    US 10,478,494, use patent

    patent.txt lines 13,382, 13,400, 13,418
    Flags
    use code U-3902
    Product numbers
    001, 002, 003
  • 15 Aug 2036 · NDA 202107 · MIFEPRISTONE

    US 9,829,495, use patent

    patent.txt line 2,772
    Flags
    use code U-1643
    Product numbers
    001
  • 15 Aug 2036 · NDA 210861 · LAROTRECTINIB SULFATE

    US 10,799,505, substance and product patent

    patent.txt lines 12,224, 12,239
    Flags
    substance product
    Product numbers
    001, 002
  • 15 Aug 2036 · NDA 211710 · LAROTRECTINIB SULFATE

    US 10,799,505, substance patent

    patent.txt line 13,076
    Flags
    substance
    Product numbers
    001
  • 16 Aug 2036 · NDA 203389 · CYSTEAMINE BITARTRATE

    US 10,143,665, use patent

    patent.txt lines 3,806, 3,830
    Flags
    use code U-1399
    Product numbers
    001, 002
  • 16 Aug 2036 · NDA 203389 · CYSTEAMINE BITARTRATE

    US 10,328,037, use patent

    patent.txt lines 3,808, 3,832
    Flags
    use code U-1399
    Product numbers
    001, 002
  • 16 Aug 2036 · NDA 203389 · CYSTEAMINE BITARTRATE

    US 10,548,859, use patent

    patent.txt lines 3,810, 3,834
    Flags
    use code U-1399
    Product numbers
    001, 002
  • 16 Aug 2036 · NDA 203389 · CYSTEAMINE BITARTRATE

    US 10,905,662, use patent

    patent.txt lines 3,812, 3,836
    Flags
    use code U-1399
    Product numbers
    001, 002
  • 16 Aug 2036 · NDA 213491 · CYSTEAMINE BITARTRATE

    US 10,143,665, use patent

    patent.txt lines 15,021, 15,045
    Flags
    use code U-1399
    Product numbers
    001, 002
  • 16 Aug 2036 · NDA 213491 · CYSTEAMINE BITARTRATE

    US 10,328,037, use patent

    patent.txt lines 15,023, 15,047
    Flags
    use code U-1399
    Product numbers
    001, 002
  • 16 Aug 2036 · NDA 213491 · CYSTEAMINE BITARTRATE

    US 10,548,859, use patent

    patent.txt lines 15,025, 15,049
    Flags
    use code U-1399
    Product numbers
    001, 002
  • 16 Aug 2036 · NDA 213491 · CYSTEAMINE BITARTRATE

    US 10,905,662, use patent

    patent.txt lines 15,027, 15,051
    Flags
    use code U-1399
    Product numbers
    001, 002
  • 19 Aug 2036 · NDA 207793 · IRINOTECAN HYDROCHLORIDE

    US 11,344,552, use patent

    patent.txt line 7,418
    Flags
    use code U-3824
    Product numbers
    001
  • 19 Aug 2036 · NDA 212436 · PALBOCICLIB

    US 11,065,250, product patent

    patent.txt lines 13,969, 13,975, 13,981
    Flags
    product
    Product numbers
    001, 002, 003
  • 25 Aug 2036 · NDA 214012 · INCLISIRAN SODIUM

    US 10,851,377, use patent

    patent.txt line 15,432
    Flags
    use code U-4249
    Product numbers
    001
  • 25 Aug 2036 · NDA 214012 · INCLISIRAN SODIUM

    US 10,851,377, use patent

    patent.txt line 15,433
    Flags
    use code U-4413
    Product numbers
    001
  • 25 Aug 2036 · NDA 214012 · INCLISIRAN SODIUM

    US 10,851,377, use patent

    patent.txt line 15,434
    Flags
    use code U-4414
    Product numbers
    001
  • 1 Sep 2036 · NDA 210450 · ELAGOLIX SODIUM

    US 10,537,572, use patent

    patent.txt line 11,387
    Flags
    use code U-2735
    Product numbers
    001
  • 1 Sep 2036 · NDA 210450 · ELAGOLIX SODIUM

    US 10,682,351, use patent

    patent.txt line 11,388
    Flags
    use code U-2850
    Product numbers
    001
  • 2 Sep 2036 · NDA 208090 · OXYCODONE

    US 10,188,644, product and use patent

    patent.txt lines 8,224, 8,232, 8,240, 8,248, 8,256
    Flags
    product use code U-1556
    Product numbers
    001, 002, 003, 004, 005
  • 2 Sep 2036 · NDA 208090 · OXYCODONE

    US 10,646,485, product and use patent

    patent.txt lines 8,225, 8,233, 8,241, 8,249, 8,257
    Flags
    product use code U-1556
    Product numbers
    001, 002, 003, 004, 005
  • 2 Sep 2036 · NDA 208090 · OXYCODONE

    US 9,737,530, product and use patent

    patent.txt lines 8,229, 8,237, 8,245, 8,253, 8,261
    Flags
    product use code U-1556
    Product numbers
    001, 002, 003, 004, 005
  • 2 Sep 2036 · NDA 208090 · OXYCODONE

    US 9,968,598, product and use patent

    patent.txt lines 8,230, 8,238, 8,246, 8,254, 8,262
    Flags
    product use code U-1556
    Product numbers
    001, 002, 003, 004, 005
  • 4 Sep 2036 · NDA 209863 · TESTOSTERONE ENANTHATE

    US 9,950,125, product and use patent

    patent.txt lines 10,938, 10,961, 10,984
    Flags
    product use code U-2418
    Product numbers
    001, 002, 003
  • 7 Sep 2036 · NDA 208147 · AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE

    US 11,590,228, product and use patent

    patent.txt line 8,274
    Flags
    product use code U-3538
    Product numbers
    001
  • 9 Sep 2036 · NDA 211929 · BUDESONIDE

    US 10,172,802, use patent

    patent.txt lines 13,242, 13,244
    Flags
    use code U-2554
    Product numbers
    001, 002
  • 9 Sep 2036 · NDA 211929 · BUDESONIDE

    US 9,707,182, product and use patent

    patent.txt lines 13,243, 13,245
    Flags
    product use code U-2554
    Product numbers
    001, 002
  • 16 Sep 2036 · NDA 214787 · REMDESIVIR

    US 10,695,361, use patent

    patent.txt line 16,126
    Flags
    use code U-3831
    Product numbers
    001
  • 16 Sep 2036 · NDA 214787 · REMDESIVIR

    US 10,695,361, use patent

    patent.txt line 16,127
    Flags
    use code U-3832
    Product numbers
    001
  • 16 Sep 2036 · NDA 214787 · REMDESIVIR

    US 10,695,361, use patent

    patent.txt line 16,163
    Flags
    use code U-3829
    Product numbers
    002
  • 16 Sep 2036 · NDA 214787 · REMDESIVIR

    US 10,695,361, use patent

    patent.txt line 16,164
    Flags
    use code U-3830
    Product numbers
    002
  • 16 Sep 2036 · NDA 214787 · REMDESIVIR

    US 11,007,208, use patent

    patent.txt line 16,129
    Flags
    use code U-3831
    Product numbers
    001
  • 16 Sep 2036 · NDA 214787 · REMDESIVIR

    US 11,007,208, use patent

    patent.txt line 16,130
    Flags
    use code U-3832
    Product numbers
    001
  • 16 Sep 2036 · NDA 214787 · REMDESIVIR

    US 11,007,208, use patent

    patent.txt line 16,166
    Flags
    use code U-3829
    Product numbers
    002
  • 16 Sep 2036 · NDA 214787 · REMDESIVIR

    US 11,007,208, use patent

    patent.txt line 16,167
    Flags
    use code U-3830
    Product numbers
    002
  • 16 Sep 2036 · NDA 214787 · REMDESIVIR

    US 11,382,926, use patent

    patent.txt line 16,135
    Flags
    use code U-3831
    Product numbers
    001
  • 16 Sep 2036 · NDA 214787 · REMDESIVIR

    US 11,382,926, use patent

    patent.txt line 16,136
    Flags
    use code U-3832
    Product numbers
    001
  • 16 Sep 2036 · NDA 214787 · REMDESIVIR

    US 11,382,926, use patent

    patent.txt line 16,169
    Flags
    use code U-3829
    Product numbers
    002
  • 16 Sep 2036 · NDA 214787 · REMDESIVIR

    US 11,382,926, use patent

    patent.txt line 16,170
    Flags
    use code U-3830
    Product numbers
    002
  • 22 Sep 2036 · NDA 215650 · CLINDAMYCIN PHOSPHATE

    US 11,129,896, use patent

    patent.txt line 17,481
    Flags
    use code U-3293
    Product numbers
    001
  • 22 Sep 2036 · NDA 215650 · CLINDAMYCIN PHOSPHATE

    US 12,303,563, product patent

    patent.txt line 17,482
    Flags
    product
    Product numbers
    001
  • 26 Sep 2036 · NDA 203826 · PHENYLEPHRINE HYDROCHLORIDE

    US 11,213,480, product patent

    patent.txt lines 4,160, 4,163
    Flags
    product
    Product numbers
    004, 005
  • 26 Sep 2036 · NDA 203826 · PHENYLEPHRINE HYDROCHLORIDE

    US 12,257,342, product patent

    patent.txt lines 4,162, 4,165
    Flags
    product
    Product numbers
    004, 005
  • 29 Sep 2036 · NDA 216675 · PERFLUOROHEXYLOCTANE

    US 10,682,315, use patent

    patent.txt line 18,917
    Flags
    use code U-4586
    Product numbers
    001
  • 29 Sep 2036 · NDA 216675 · PERFLUOROHEXYLOCTANE

    US 11,357,738, product patent

    patent.txt line 18,918
    Flags
    product
    Product numbers
    001
  • 29 Sep 2036 · NDA 216675 · PERFLUOROHEXYLOCTANE

    US 12,128,010, product patent

    patent.txt line 18,920
    Flags
    product
    Product numbers
    001
  • 29 Sep 2036 · NDA 217469 · CYCLOSPORINE

    US 12,496,326, use patent

    patent.txt line 19,984
    Flags
    use code U-3627
    Product numbers
    001
  • 3 Oct 2036 · NDA 217639 · ELACESTRANT HYDROCHLORIDE

    US 10,420,734, use patent

    patent.txt lines 20,047, 20,054
    Flags
    use code U-3524
    Product numbers
    001, 002
  • 7 Oct 2036 · NDA 208742 · DEXAMETHASONE

    US 12,150,896, use patent

    patent.txt line 9,287
    Flags
    use code U-1680
    Product numbers
    001
  • 7 Oct 2036 · NDA 208742 · DEXAMETHASONE

    US 12,150,896, use patent

    patent.txt line 9,288
    Flags
    use code U-3455
    Product numbers
    001
  • 7 Oct 2036 · NDA 217171 · PEGCETACOPLAN

    US 12,528,836, use patent

    patent.txt line 19,282
    Flags
    use code U-4394
    Product numbers
    001
  • 11 Oct 2036 · NDA 217338 · DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; NAPROXEN SODIUM

    US 11,278,506, product patent

    patent.txt line 19,842
    Flags
    product
    Product numbers
    001
  • 11 Oct 2036 · NDA 217338 · DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; NAPROXEN SODIUM

    US 12,257,218, product patent

    patent.txt line 19,843
    Flags
    product
    Product numbers
    001
  • 11 Oct 2036 · NDA 217338 · DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; NAPROXEN SODIUM

    US 12,370,189, product patent

    patent.txt line 19,844
    Flags
    product
    Product numbers
    001
  • 13 Oct 2036 · NDA 020965 · AMINOLEVULINIC ACID HYDROCHLORIDE

    US 11,179,574, use patent

    patent.txt line 391
    Flags
    use code U-804
    Product numbers
    001
  • 13 Oct 2036 · NDA 020965 · AMINOLEVULINIC ACID HYDROCHLORIDE

    US 11,697,028, use patent

    patent.txt line 395
    Flags
    use code U-804
    Product numbers
    001
  • 13 Oct 2036 · NDA 020965 · AMINOLEVULINIC ACID HYDROCHLORIDE

    US 12,290,700, use patent

    patent.txt line 396
    Flags
    use code U-804
    Product numbers
    001
  • 15 Oct 2036 · NDA 207793 · IRINOTECAN HYDROCHLORIDE

    US 10,456,360, product patent

    patent.txt line 7,415
    Flags
    product
    Product numbers
    001
  • 15 Oct 2036 · NDA 207793 · IRINOTECAN HYDROCHLORIDE

    US 10,993,914, product patent

    patent.txt line 7,417
    Flags
    product
    Product numbers
    001
  • 15 Oct 2036 · NDA 207793 · IRINOTECAN HYDROCHLORIDE

    US 12,059,497, product patent

    patent.txt line 7,420
    Flags
    product
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 10,202,393, product patent

    patent.txt line 13,050
    Flags
    product
    Product numbers
    003
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 10,344,036, product patent

    patent.txt line 13,025
    Flags
    product
    Product numbers
    002
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 10,519,164, product patent

    patent.txt line 12,972
    Flags
    product
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 10,550,126, use patent

    patent.txt line 13,026
    Flags
    use code U-3298
    Product numbers
    002
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 10,597,400, use patent

    patent.txt line 12,973
    Flags
    use code U-3255
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 10,730,883, product patent

    patent.txt line 13,027
    Flags
    product
    Product numbers
    002
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 10,981,923, substance patent

    patent.txt lines 12,974, 13,028, 13,051
    Flags
    substance
    Product numbers
    001, 002, 003
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 10,981,924, product patent

    patent.txt lines 12,975, 13,029
    Flags
    product
    Product numbers
    001, 002
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 10,995,095, use patent

    patent.txt line 12,976
    Flags
    use code U-3298
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,186,584, substance patent

    patent.txt lines 12,977, 13,030, 13,052
    Flags
    substance
    Product numbers
    001, 002, 003
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,198,697, product patent

    patent.txt lines 12,978, 13,031, 13,053
    Flags
    product
    Product numbers
    001, 002, 003
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,365,198, use patent

    patent.txt line 12,979
    Flags
    use code U-3275
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,365,198, use patent

    patent.txt line 12,980
    Flags
    use code U-3946
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,512,092, use patent

    patent.txt line 12,981
    Flags
    use code U-3275
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,512,092, use patent

    patent.txt line 12,982
    Flags
    use code U-3371
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,512,092, use patent

    patent.txt line 12,983
    Flags
    use code U-3487
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,512,092, use patent

    patent.txt line 12,984
    Flags
    use code U-3946
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,524,964, use patent

    patent.txt line 12,985
    Flags
    use code U-3371
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,535,624, use patent

    patent.txt line 12,986
    Flags
    use code U-3255
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,535,625, use patent

    patent.txt line 12,987
    Flags
    use code U-3298
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,535,626, use patent

    patent.txt line 13,032
    Flags
    use code U-3298
    Product numbers
    002
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,661,425, substance and product patent

    patent.txt lines 12,992, 13,037, 13,058
    Flags
    substance product
    Product numbers
    001, 002, 003
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,680,069, substance and product patent

    patent.txt lines 12,993, 13,038, 13,059
    Flags
    substance product
    Product numbers
    001, 002, 003
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,718,627, substance and product patent

    patent.txt lines 12,994, 13,039, 13,060
    Flags
    substance product
    Product numbers
    001, 002, 003
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,767,326, use patent

    patent.txt lines 12,995, 13,040
    Flags
    use code U-3298
    Product numbers
    001, 002
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,773,105, substance and product patent

    patent.txt lines 12,996, 13,041, 13,061
    Flags
    substance product
    Product numbers
    001, 002, 003
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,773,106, use patent

    patent.txt line 12,997
    Flags
    use code U-3275
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,773,106, use patent

    patent.txt line 12,998
    Flags
    use code U-3371
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,773,106, use patent

    patent.txt line 12,999
    Flags
    use code U-3487
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,773,106, use patent

    patent.txt line 13,000
    Flags
    use code U-3946
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,780,847, product patent

    patent.txt line 13,001
    Flags
    product
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,780,848, use patent

    patent.txt line 13,002
    Flags
    use code U-3371
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,787,815, product patent

    patent.txt line 13,003
    Flags
    product
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,795,175, use patent

    patent.txt line 13,004
    Flags
    use code U-3255
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,976,077, use patent

    patent.txt line 13,005
    Flags
    use code U-3298
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,993,605, use patent

    patent.txt line 13,006
    Flags
    use code U-3275
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,993,605, use patent

    patent.txt line 13,007
    Flags
    use code U-3946
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 11,993,606, use patent

    patent.txt line 13,008
    Flags
    use code U-3487
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 12,077,545, product patent

    patent.txt lines 13,009, 13,042, 13,062
    Flags
    product
    Product numbers
    001, 002, 003
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 12,091,415, product patent

    patent.txt line 13,043
    Flags
    product
    Product numbers
    002
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 12,103,933, product patent

    patent.txt line 13,010
    Flags
    product
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 12,110,297, product patent

    patent.txt line 13,011
    Flags
    product
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 12,110,298, substance and product patent

    patent.txt lines 13,012, 13,044, 13,063
    Flags
    substance product
    Product numbers
    001, 002, 003
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 12,116,373, product patent

    patent.txt line 13,045
    Flags
    product
    Product numbers
    002
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 12,134,621, product patent

    patent.txt line 13,064
    Flags
    product
    Product numbers
    003
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 12,365,689, use patent

    patent.txt line 13,013
    Flags
    use code U-3945
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 12,570,664, use patent

    patent.txt line 13,014
    Flags
    use code U-4454
    Product numbers
    001
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 9,951,080, substance and product patent

    patent.txt lines 13,022, 13,048, 13,067
    Flags
    substance product
    Product numbers
    001, 002, 003
  • 17 Oct 2036 · NDA 211675 · UPADACITINIB

    US 9,963,459, product patent

    patent.txt line 13,023
    Flags
    product
    Product numbers
    001
  • 17 Oct 2036 · NDA 214860 · SODIUM PHENYLBUTYRATE

    US 11,154,521, product patent

    patent.txt lines 16,244, 16,247, 16,250, 16,253, 16,256, 16,259, 16,262, 16,265
    Flags
    product
    Product numbers
    001, 002, 003, 004, 005, 006, 007, 008
  • 17 Oct 2036 · NDA 214860 · SODIUM PHENYLBUTYRATE

    US 11,202,767, use patent

    patent.txt lines 16,245, 16,248, 16,251, 16,254, 16,257, 16,260, 16,263, 16,266
    Flags
    use code U-3502
    Product numbers
    001, 002, 003, 004, 005, 006, 007, 008
  • 17 Oct 2036 · NDA 214860 · SODIUM PHENYLBUTYRATE

    US 11,433,041, product patent

    patent.txt lines 16,246, 16,249, 16,252, 16,255, 16,258, 16,261, 16,264, 16,267
    Flags
    product
    Product numbers
    001, 002, 003, 004, 005, 006, 007, 008
  • 17 Oct 2036 · NDA 218347 · UPADACITINIB

    US 10,981,923, substance patent

    patent.txt line 20,968
    Flags
    substance
    Product numbers
    001
  • 17 Oct 2036 · NDA 218347 · UPADACITINIB

    US 11,186,584, substance patent

    patent.txt line 20,969
    Flags
    substance
    Product numbers
    001
  • 17 Oct 2036 · NDA 218347 · UPADACITINIB

    US 11,661,425, substance patent

    patent.txt line 20,970
    Flags
    substance
    Product numbers
    001
  • 17 Oct 2036 · NDA 218347 · UPADACITINIB

    US 11,680,069, substance patent

    patent.txt line 20,971
    Flags
    substance
    Product numbers
    001
  • 17 Oct 2036 · NDA 218347 · UPADACITINIB

    US 11,718,627, substance patent

    patent.txt line 20,972
    Flags
    substance
    Product numbers
    001
  • 17 Oct 2036 · NDA 218347 · UPADACITINIB

    US 11,773,105, substance patent

    patent.txt line 20,973
    Flags
    substance
    Product numbers
    001
  • 17 Oct 2036 · NDA 218347 · UPADACITINIB

    US 12,110,298, substance patent

    patent.txt line 20,974
    Flags
    substance
    Product numbers
    001
  • 17 Oct 2036 · NDA 218347 · UPADACITINIB

    US 12,365,689, use patent

    patent.txt line 20,975
    Flags
    use code U-3945
    Product numbers
    001
  • 17 Oct 2036 · NDA 218347 · UPADACITINIB

    US 9,951,080, substance patent

    patent.txt line 20,978
    Flags
    substance
    Product numbers
    001
  • 18 Oct 2036 · NDA 211192 · IVOSIDENIB

    US 10,653,710, use patent

    patent.txt line 12,514
    Flags
    use code U-3387
    Product numbers
    001
  • 20 Oct 2036 · NDA 207534 · EPINEPHRINE

    US 11,141,540, product and use patent

    patent.txt lines 7,344–7,345
    Flags
    product use code U-3379
    Product numbers
    001, 002
  • 28 Oct 2036 · NDA 209241 · VALBENAZINE TOSYLATE

    US 10,065,952, substance and product and use patent

    patent.txt lines 9,922, 9,955, 9,988
    Flags
    substance product use code U-1995
    Product numbers
    001, 002, 003
  • 28 Oct 2036 · NDA 209241 · VALBENAZINE TOSYLATE

    US 10,065,952, substance and product and use patent

    patent.txt lines 9,923, 9,956, 9,989
    Flags
    substance product use code U-3055
    Product numbers
    001, 002, 003
  • 28 Oct 2036 · NDA 209241 · VALBENAZINE TOSYLATE

    US 10,844,058, substance and product and use patent

    patent.txt lines 9,924, 9,957, 9,990
    Flags
    substance product use code U-1995
    Product numbers
    001, 002, 003
  • 28 Oct 2036 · NDA 209241 · VALBENAZINE TOSYLATE

    US 10,844,058, substance and product and use patent

    patent.txt lines 9,925, 9,958, 9,991
    Flags
    substance product use code U-3055
    Product numbers
    001, 002, 003
  • 28 Oct 2036 · NDA 209241 · VALBENAZINE TOSYLATE

    US 10,851,103, substance and product and use patent

    patent.txt lines 9,926, 9,959, 9,992
    Flags
    substance product use code U-1995
    Product numbers
    001, 002, 003
  • 28 Oct 2036 · NDA 209241 · VALBENAZINE TOSYLATE

    US 10,851,103, substance and product and use patent

    patent.txt lines 9,927, 9,960, 9,993
    Flags
    substance product use code U-3055
    Product numbers
    001, 002, 003
  • 28 Oct 2036 · NDA 209241 · VALBENAZINE TOSYLATE

    US 10,851,104, substance and use patent

    patent.txt lines 9,928, 9,961, 9,994
    Flags
    substance use code U-1995
    Product numbers
    001, 002, 003
  • 28 Oct 2036 · NDA 209241 · VALBENAZINE TOSYLATE

    US 10,851,104, substance and use patent

    patent.txt lines 9,929, 9,962, 9,995
    Flags
    substance use code U-3055
    Product numbers
    001, 002, 003
  • 28 Oct 2036 · NDA 209478 · SPIRONOLACTONE

    US 10,493,083, product patent

    patent.txt line 10,395
    Flags
    product
    Product numbers
    001
  • 28 Oct 2036 · NDA 209478 · SPIRONOLACTONE

    US 10,624,906, product patent

    patent.txt line 10,396
    Flags
    product
    Product numbers
    001
  • 28 Oct 2036 · NDA 209478 · SPIRONOLACTONE

    US 10,660,907, product patent

    patent.txt line 10,397
    Flags
    product
    Product numbers
    001
  • 28 Oct 2036 · NDA 209478 · SPIRONOLACTONE

    US 10,888,570, product patent

    patent.txt line 10,398
    Flags
    product
    Product numbers
    001
  • 28 Oct 2036 · NDA 209478 · SPIRONOLACTONE

    US 11,389,461, product patent

    patent.txt line 10,399
    Flags
    product
    Product numbers
    001
  • 28 Oct 2036 · NDA 209478 · SPIRONOLACTONE

    US 11,395,828, use patent

    patent.txt line 10,400
    Flags
    use code U-2109
    Product numbers
    001
  • 28 Oct 2036 · NDA 209478 · SPIRONOLACTONE

    US 11,395,828, use patent

    patent.txt line 10,401
    Flags
    use code U-3401
    Product numbers
    001
  • 28 Oct 2036 · NDA 209478 · SPIRONOLACTONE

    US 11,395,828, use patent

    patent.txt line 10,402
    Flags
    use code U-3402
    Product numbers
    001
  • 28 Oct 2036 · NDA 209478 · SPIRONOLACTONE

    US 11,491,166, product patent

    patent.txt line 10,403
    Flags
    product
    Product numbers
    001
  • 28 Oct 2036 · NDA 209478 · SPIRONOLACTONE

    US 9,757,394, product and use patent

    patent.txt line 10,404
    Flags
    product use code U-2109
    Product numbers
    001
  • 28 Oct 2036 · NDA 217865 · GIVINOSTAT HYDROCHLORIDE

    US 10,688,047, product and use patent

    patent.txt line 20,747
    Flags
    product use code U-3885
    Product numbers
    001
  • 28 Oct 2036 · NDA 218390 · VALBENAZINE TOSYLATE

    US 10,065,952, substance and product and use patent

    patent.txt lines 20,980, 21,013, 21,046
    Flags
    substance product use code U-1995
    Product numbers
    001, 002, 003
  • 28 Oct 2036 · NDA 218390 · VALBENAZINE TOSYLATE

    US 10,065,952, substance and product and use patent

    patent.txt lines 20,981, 21,014, 21,047
    Flags
    substance product use code U-3055
    Product numbers
    001, 002, 003
  • 28 Oct 2036 · NDA 218390 · VALBENAZINE TOSYLATE

    US 10,844,058, substance and product and use patent

    patent.txt lines 20,982, 21,015, 21,048
    Flags
    substance product use code U-1995
    Product numbers
    001, 002, 003
  • 28 Oct 2036 · NDA 218390 · VALBENAZINE TOSYLATE

    US 10,844,058, substance and product and use patent

    patent.txt lines 20,983, 21,016, 21,049
    Flags
    substance product use code U-3055
    Product numbers
    001, 002, 003
  • 28 Oct 2036 · NDA 218390 · VALBENAZINE TOSYLATE

    US 10,851,103, substance and product and use patent

    patent.txt lines 20,984, 21,017, 21,050
    Flags
    substance product use code U-1995
    Product numbers
    001, 002, 003
  • 28 Oct 2036 · NDA 218390 · VALBENAZINE TOSYLATE

    US 10,851,103, substance and product and use patent

    patent.txt lines 20,985, 21,018, 21,051
    Flags
    substance product use code U-3055
    Product numbers
    001, 002, 003
  • 28 Oct 2036 · NDA 218390 · VALBENAZINE TOSYLATE

    US 10,851,104, substance and use patent

    patent.txt lines 20,986, 21,019, 21,052
    Flags
    substance use code U-1995
    Product numbers
    001, 002, 003
  • 28 Oct 2036 · NDA 218390 · VALBENAZINE TOSYLATE

    US 10,851,104, substance and use patent

    patent.txt lines 20,987, 21,020, 21,053
    Flags
    substance use code U-3055
    Product numbers
    001, 002, 003
  • 1 Nov 2036 · NDA 213721 · PRALSETINIB

    US 10,030,005, substance and product and use patent

    patent.txt line 15,215
    Flags
    substance product use code U-2952
    Product numbers
    001
  • 1 Nov 2036 · NDA 213721 · PRALSETINIB

    US 10,030,005, substance and product and use patent

    patent.txt line 15,216
    Flags
    substance product use code U-3002
    Product numbers
    001
  • 1 Nov 2036 · NDA 213721 · PRALSETINIB

    US 12,655,128, substance and product patent

    patent.txt line 15,222
    Flags
    substance product
    Product numbers
    001
  • 5 Nov 2036 · NDA 213436 · DIHYDROERGOTAMINE MESYLATE

    US 11,266,799, product patent

    patent.txt line 15,016
    Flags
    product
    Product numbers
    001
  • 8 Nov 2036 · NDA 210251 · BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

    US 10,548,846, product patent

    patent.txt line 11,212
    Flags
    product
    Product numbers
    001
  • 8 Nov 2036 · NDA 210251 · BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

    US 11,744,802, product patent

    patent.txt line 11,213
    Flags
    product
    Product numbers
    001
  • 8 Nov 2036 · NDA 210251 · BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

    US 12,594,244, product and use patent

    patent.txt lines 11,214, 11,223
    Flags
    product use code U-257
    Product numbers
    001, 002
  • 8 Nov 2036 · NDA 213535 · RISDIPLAM

    US 11,938,136, product patent

    patent.txt line 15,082
    Flags
    product
    Product numbers
    001
  • 12 Nov 2036 · NDA 208437 · GLYCOPYRROLATE

    US 10,688,518, product patent

    patent.txt line 8,622
    Flags
    product
    Product numbers
    001
  • 22 Nov 2036 · NDA 210942 · COLCHICINE

    US 10,383,820, product and use patent

    patent.txt line 12,428
    Flags
    product use code U-2814
    Product numbers
    001
  • 22 Nov 2036 · NDA 210942 · COLCHICINE

    US 10,383,821, product patent

    patent.txt line 12,429
    Flags
    product
    Product numbers
    001
  • 22 Nov 2036 · NDA 210942 · COLCHICINE

    US 12,274,751, use patent

    patent.txt line 12,430
    Flags
    use code U-2814
    Product numbers
    001
  • 22 Nov 2036 · NDA 210942 · COLCHICINE

    US 12,514,819, use patent

    patent.txt line 12,431
    Flags
    use code U-2814
    Product numbers
    001
  • 22 Nov 2036 · NDA 210942 · COLCHICINE

    US 9,907,751, product patent

    patent.txt line 12,432
    Flags
    product
    Product numbers
    001
  • 25 Nov 2036 · NDA 216264 · INDIGOTINDISULFONATE SODIUM

    US 11,845,867, substance patent

    patent.txt line 18,475
    Flags
    substance
    Product numbers
    001
  • 29 Nov 2036 · NDA 210807 · DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE

    US 10,603,282, product patent

    patent.txt line 12,155
    Flags
    product
    Product numbers
    001
  • 29 Nov 2036 · NDA 210807 · DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE

    US 10,842,751, product patent

    patent.txt line 12,156
    Flags
    product
    Product numbers
    001
  • 30 Nov 2036 · NDA 210566 · HALOBETASOL PROPIONATE

    US 10,857,159, product patent

    patent.txt line 12,026
    Flags
    product
    Product numbers
    001
  • 30 Nov 2036 · NDA 210566 · HALOBETASOL PROPIONATE

    US 11,020,407, product and use patent

    patent.txt line 12,027
    Flags
    product use code U-3143
    Product numbers
    001
  • 1 Dec 2036 · NDA 207947 · SELEXIPAG

    US 10,821,108, product and use patent

    patent.txt lines 7,695, 7,707, 7,719, 7,731, 7,743, 7,755, 7,767, 7,779, 7,791, 7,803
    Flags
    product use code U-2992
    Product numbers
    001, 002, 003, 004, 005, 006, 007, 008, 010, 011
  • 1 Dec 2036 · NDA 207947 · SELEXIPAG

    US 10,828,298, product and use patent

    patent.txt lines 7,697, 7,709, 7,721, 7,733, 7,745, 7,757, 7,769, 7,781, 7,793, 7,805
    Flags
    product use code U-2991
    Product numbers
    001, 002, 003, 004, 005, 006, 007, 008, 010, 011
  • 1 Dec 2036 · NDA 210632 · LEVOTHYROXINE SODIUM

    US 10,398,669, product patent

    patent.txt lines 12,051, 12,055, 12,059
    Flags
    product
    Product numbers
    001, 002, 003
  • 1 Dec 2036 · NDA 210632 · LEVOTHYROXINE SODIUM

    US 11,135,190, product patent

    patent.txt lines 12,052, 12,056, 12,060
    Flags
    product
    Product numbers
    001, 002, 003
  • 1 Dec 2036 · NDA 210632 · LEVOTHYROXINE SODIUM

    US 12,636,270, product patent

    patent.txt lines 12,053, 12,057, 12,061
    Flags
    product
    Product numbers
    001, 002, 003
  • 1 Dec 2036 · NDA 210632 · LEVOTHYROXINE SODIUM

    US 9,782,376, product patent

    patent.txt lines 12,054, 12,058, 12,062
    Flags
    product
    Product numbers
    001, 002, 003
  • 2 Dec 2036 · NDA 213137 · VOXELOTOR

    US 11,020,382, use patent

    patent.txt lines 14,671, 14,684
    Flags
    use code U-3133
    Product numbers
    001, 002
  • 2 Dec 2036 · NDA 213137 · VOXELOTOR

    US 11,020,382, use patent

    patent.txt lines 14,672, 14,685
    Flags
    use code U-3134
    Product numbers
    001, 002
  • 2 Dec 2036 · NDA 213137 · VOXELOTOR

    US 11,944,612, use patent

    patent.txt lines 14,674, 14,687
    Flags
    use code U-3893
    Product numbers
    001, 002
  • 2 Dec 2036 · NDA 216157 · VOXELOTOR

    US 11,020,382, use patent

    patent.txt line 18,369
    Flags
    use code U-3133
    Product numbers
    001
  • 2 Dec 2036 · NDA 216157 · VOXELOTOR

    US 11,020,382, use patent

    patent.txt line 18,370
    Flags
    use code U-3134
    Product numbers
    001
  • 2 Dec 2036 · NDA 216157 · VOXELOTOR

    US 11,944,612, use patent

    patent.txt line 18,372
    Flags
    use code U-3893
    Product numbers
    001
  • 7 Dec 2036 · NDA 208437 · GLYCOPYRROLATE

    US 10,744,277, product and use patent

    patent.txt line 8,623
    Flags
    product use code U-2941
    Product numbers
    001
  • 7 Dec 2036 · NDA 219019 · FITUSIRAN SODIUM

    US 11,091,759, use patent

    patent.txt lines 21,459, 21,463
    Flags
    use code U-4165
    Product numbers
    001, 002
  • 8 Dec 2036 · NDA 209400 · OMEPRAZOLE

    US 10,076,494, product patent

    patent.txt line 10,324
    Flags
    product
    Product numbers
    001
  • 8 Dec 2036 · NDA 209400 · OMEPRAZOLE

    US 10,835,488, product patent

    patent.txt line 10,325
    Flags
    product
    Product numbers
    001
  • 8 Dec 2036 · NDA 214278 · ESOMEPRAZOLE MAGNESIUM

    US 10,076,494, product patent

    patent.txt line 15,666
    Flags
    product
    Product numbers
    001
  • 8 Dec 2036 · NDA 214278 · ESOMEPRAZOLE MAGNESIUM

    US 10,835,488, product patent

    patent.txt line 15,667
    Flags
    product
    Product numbers
    001
  • 14 Dec 2036 · NDA 218709 · MAVORIXAFOR

    US 10,953,003, product patent

    patent.txt line 21,157
    Flags
    product
    Product numbers
    001
  • 16 Dec 2036 · NDA 216059 · PIRTOBRUTINIB

    US 10,342,780, substance and product patent

    patent.txt lines 18,185, 18,196
    Flags
    substance product
    Product numbers
    001, 002
  • 16 Dec 2036 · NDA 216059 · PIRTOBRUTINIB

    US 10,464,905, use patent

    patent.txt lines 18,186, 18,197
    Flags
    use code U-3518
    Product numbers
    001, 002
  • 16 Dec 2036 · NDA 216059 · PIRTOBRUTINIB

    US 10,464,905, use patent

    patent.txt lines 18,187, 18,198
    Flags
    use code U-4362
    Product numbers
    001, 002
  • 16 Dec 2036 · NDA 216059 · PIRTOBRUTINIB

    US 10,695,323, substance and product and use patent

    patent.txt lines 18,188, 18,199
    Flags
    substance product use code U-3518
    Product numbers
    001, 002
  • 16 Dec 2036 · NDA 216059 · PIRTOBRUTINIB

    US 10,695,323, substance and product and use patent

    patent.txt lines 18,189, 18,200
    Flags
    substance product use code U-4362
    Product numbers
    001, 002
  • 16 Dec 2036 · NDA 216059 · PIRTOBRUTINIB

    US 10,918,622, use patent

    patent.txt lines 18,190, 18,201
    Flags
    use code U-3518
    Product numbers
    001, 002
  • 16 Dec 2036 · NDA 216059 · PIRTOBRUTINIB

    US 10,918,622, use patent

    patent.txt lines 18,191, 18,202
    Flags
    use code U-4362
    Product numbers
    001, 002
  • 16 Dec 2036 · NDA 216059 · PIRTOBRUTINIB

    US 12,220,401, substance and product and use patent

    patent.txt lines 18,193, 18,204
    Flags
    substance product use code U-3518
    Product numbers
    001, 002
  • 16 Dec 2036 · NDA 216059 · PIRTOBRUTINIB

    US 12,220,401, substance and product and use patent

    patent.txt lines 18,194, 18,205
    Flags
    substance product use code U-4362
    Product numbers
    001, 002
  • 19 Dec 2036 · NDA 022555 · HEXAMINOLEVULINATE HYDROCHLORIDE

    US 10,556,010, use patent

    patent.txt line 2,081
    Flags
    use code U-2250
    Product numbers
    001
  • 19 Dec 2036 · NDA 022555 · HEXAMINOLEVULINATE HYDROCHLORIDE

    US 11,311,620, use patent

    patent.txt line 2,083
    Flags
    use code U-2250
    Product numbers
    001
  • 20 Dec 2036 · NDA 212102 · FENFLURAMINE HYDROCHLORIDE

    US 10,947,183, substance and product patent

    patent.txt line 13,559
    Flags
    substance product
    Product numbers
    001
  • 22 Dec 2036 · NDA 209241 · VALBENAZINE TOSYLATE

    US 10,906,902, substance and product patent

    patent.txt lines 9,935, 9,968, 10,001
    Flags
    substance product
    Product numbers
    001, 002, 003
  • 22 Dec 2036 · NDA 209241 · VALBENAZINE TOSYLATE

    US 10,906,903, substance and product patent

    patent.txt lines 9,936, 9,969, 10,002
    Flags
    substance product
    Product numbers
    001, 002, 003
  • 22 Dec 2036 · NDA 209241 · VALBENAZINE TOSYLATE

    US 10,919,892, substance and product patent

    patent.txt lines 9,940, 9,973, 10,006
    Flags
    substance product
    Product numbers
    001, 002, 003
  • 22 Dec 2036 · NDA 218390 · VALBENAZINE TOSYLATE

    US 10,906,902, substance and product patent

    patent.txt lines 20,993, 21,026, 21,059
    Flags
    substance product
    Product numbers
    001, 002, 003
  • 22 Dec 2036 · NDA 218390 · VALBENAZINE TOSYLATE

    US 10,906,903, substance and product patent

    patent.txt lines 20,994, 21,027, 21,060
    Flags
    substance product
    Product numbers
    001, 002, 003
  • 22 Dec 2036 · NDA 218390 · VALBENAZINE TOSYLATE

    US 10,919,892, substance and product patent

    patent.txt lines 20,998, 21,031, 21,064
    Flags
    substance product
    Product numbers
    001, 002, 003
  • 22 Dec 2036 · NDA 218709 · MAVORIXAFOR

    US 10,610,527, use patent

    patent.txt line 21,156
    Flags
    use code U-3932
    Product numbers
    001
  • 22 Dec 2036 · NDA 218709 · MAVORIXAFOR

    US 11,219,621, use patent

    patent.txt line 21,159
    Flags
    use code U-3932
    Product numbers
    001
  • 23 Dec 2036 · NDA 208219 · LOTEPREDNOL ETABONATE

    US 10,596,107, product and use patent

    patent.txt line 8,348
    Flags
    product use code U-2764
    Product numbers
    001
  • 29 Dec 2036 · NDA 215211 · MIGLUSTAT

    US 11,278,601, product and use patent

    patent.txt line 16,585
    Flags
    product use code U-3726
    Product numbers
    001
  • 29 Dec 2036 · NDA 215211 · MIGLUSTAT

    US 12,414,985, use patent

    patent.txt line 16,588
    Flags
    use code U-3726
    Product numbers
    001
  • 30 Dec 2036 · NDA 212304 · DONEPEZIL HYDROCHLORIDE

    US 12,161,767, substance and product and use patent

    patent.txt lines 13,817, 13,828
    Flags
    substance product use code U-3334
    Product numbers
    001, 002
  • 30 Dec 2036 · NDA 212304 · DONEPEZIL HYDROCHLORIDE

    US 12,168,075, use patent

    patent.txt lines 13,818, 13,829
    Flags
    use code U-3334
    Product numbers
    001, 002
  • 31 Dec 2036 · NDA 219474 · DIFAMILAST

    US 10,588,893, substance and product patent

    patent.txt line 21,745
    Flags
    substance product
    Product numbers
    001

Pediatric exclusivity, as listed (31)

  • 27 Jul 2036 · NDA 022433 · TICAGRELOR

    US 10,300,065 with pediatric exclusivity, as listed

    patent.txt lines 1,897, 1,902
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002
  • 23 Aug 2036 · NDA 206947 · LENVATINIB MESYLATE

    US 11,090,386 with pediatric exclusivity, as listed

    patent.txt lines 6,878, 6,899
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002
  • 3 Sep 2036 · NDA 206947 · LENVATINIB MESYLATE

    US 12,083,112 with pediatric exclusivity, as listed

    patent.txt lines 6,882, 6,903
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002
  • 3 Sep 2036 · NDA 210563 · IBRUTINIB

    US 10,010,507 with pediatric exclusivity, as listed

    patent.txt lines 11,592, 11,698, 11,802, 11,906
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004
  • 3 Sep 2036 · NDA 210563 · IBRUTINIB

    US 10,213,386 with pediatric exclusivity, as listed

    patent.txt lines 11,600, 11,706, 11,810, 11,914
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004
  • 3 Sep 2036 · NDA 210563 · IBRUTINIB

    US 10,828,259 with pediatric exclusivity, as listed

    patent.txt lines 11,621, 11,725, 11,829, 11,936
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004
  • 3 Sep 2036 · NDA 210563 · IBRUTINIB

    US 9,655,857 with pediatric exclusivity, as listed

    patent.txt lines 11,679, 11,783, 11,887, 11,996
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004
  • 7 Sep 2036 · NDA 208082 · DEUTETRABENAZINE

    US 10,959,996 with pediatric exclusivity, as listed

    patent.txt lines 8,111, 8,143, 8,175
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003
  • 7 Sep 2036 · NDA 208082 · DEUTETRABENAZINE

    US 11,357,772 with pediatric exclusivity, as listed

    patent.txt lines 8,116, 8,148, 8,180
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003
  • 7 Sep 2036 · NDA 208082 · DEUTETRABENAZINE

    US 11,446,291 with pediatric exclusivity, as listed

    patent.txt lines 8,119, 8,151, 8,183
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003
  • 7 Sep 2036 · NDA 208082 · DEUTETRABENAZINE

    US 11,564,917 with pediatric exclusivity, as listed

    patent.txt lines 8,121, 8,153, 8,185
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003
  • 7 Sep 2036 · NDA 208082 · DEUTETRABENAZINE

    US 11,648,244 with pediatric exclusivity, as listed

    patent.txt lines 8,123, 8,155, 8,187
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003
  • 7 Sep 2036 · NDA 208082 · DEUTETRABENAZINE

    US 12,016,858 with pediatric exclusivity, as listed

    patent.txt lines 8,129, 8,161, 8,193
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003
  • 7 Sep 2036 · NDA 216354 · DEUTETRABENAZINE

    US 10,959,996 with pediatric exclusivity, as listed

    patent.txt lines 18,524, 18,554, 18,584, 18,614, 18,644, 18,674, 18,704, 18,734
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004, 005, 006, 007, 008
  • 7 Sep 2036 · NDA 216354 · DEUTETRABENAZINE

    US 11,357,772 with pediatric exclusivity, as listed

    patent.txt lines 18,531, 18,561, 18,591, 18,621, 18,651, 18,681, 18,711, 18,741
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004, 005, 006, 007, 008
  • 7 Sep 2036 · NDA 216354 · DEUTETRABENAZINE

    US 11,446,291 with pediatric exclusivity, as listed

    patent.txt lines 18,534, 18,564, 18,594, 18,624, 18,654, 18,684, 18,714, 18,744
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004, 005, 006, 007, 008
  • 7 Sep 2036 · NDA 216354 · DEUTETRABENAZINE

    US 11,564,917 with pediatric exclusivity, as listed

    patent.txt lines 18,536, 18,566, 18,596, 18,626, 18,656, 18,686, 18,716, 18,746
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004, 005, 006, 007, 008
  • 7 Sep 2036 · NDA 216354 · DEUTETRABENAZINE

    US 11,648,244 with pediatric exclusivity, as listed

    patent.txt lines 18,538, 18,568, 18,598, 18,628, 18,658, 18,688, 18,718, 18,748
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004, 005, 006, 007, 008
  • 7 Sep 2036 · NDA 216354 · DEUTETRABENAZINE

    US 12,016,858 with pediatric exclusivity, as listed

    patent.txt lines 18,542, 18,572, 18,602, 18,632, 18,662, 18,692, 18,722, 18,752
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004, 005, 006, 007, 008
  • 30 Sep 2036 · NDA 213801 · MIRABEGRON

    US 10,058,536 with pediatric exclusivity, as listed

    patent.txt line 15,273
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001
  • 14 Oct 2036 · NDA 209092 · RIBOCICLIB SUCCINATE

    US 10,799,506 with pediatric exclusivity, as listed

    patent.txt line 9,685
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001
  • 14 Oct 2036 · NDA 209092 · RIBOCICLIB SUCCINATE

    US 12,064,434 with pediatric exclusivity, as listed

    patent.txt line 9,687
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001
  • 14 Oct 2036 · NDA 209092 · RIBOCICLIB SUCCINATE

    US 12,419,894 with pediatric exclusivity, as listed

    patent.txt line 9,689
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001
  • 14 Oct 2036 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE

    US 10,799,506 with pediatric exclusivity, as listed

    patent.txt line 11,032
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001
  • 14 Oct 2036 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE

    US 12,064,434 with pediatric exclusivity, as listed

    patent.txt line 11,034
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001
  • 14 Oct 2036 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE

    US 12,419,894 with pediatric exclusivity, as listed

    patent.txt line 11,036
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001
  • 3 Nov 2036 · NDA 020845 · NITRIC OXIDE

    US 9,770,570 with pediatric exclusivity, as listed

    patent.txt line 246
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    003
  • 24 Dec 2036 · NDA 209394 · GLECAPREVIR; PIBRENTASVIR

    US 11,246,866 with pediatric exclusivity, as listed

    patent.txt line 10,305
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001
  • 29 Dec 2036 · NDA 206192 · COBIMETINIB FUMARATE

    US 10,478,400 with pediatric exclusivity, as listed

    patent.txt line 6,431
    Flags
    substance product pediatric, as listed by FDA (from the base row)
    Product numbers
    001
  • 30 Dec 2036 · NDA 206192 · COBIMETINIB FUMARATE

    US 10,590,102 with pediatric exclusivity, as listed

    patent.txt line 6,433
    Flags
    substance product pediatric, as listed by FDA (from the base row)
    Product numbers
    001
  • 30 Dec 2036 · NDA 206192 · COBIMETINIB FUMARATE

    US 11,254,649 with pediatric exclusivity, as listed

    patent.txt line 6,437
    Flags
    substance product pediatric, as listed by FDA (from the base row)
    Product numbers
    001